Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of IMS Health Holdings Inc (NYSE: IMS) acted responsibly on behalf of investors’ profitability in the planned sale to Quintiles Transnational Holdings Inc (NYSE: Q).

On May 3, 2016, IMS Health Holdings Inc (NYSE: IMS) and Quintiles Transnational Holdings Inc (NYSE: Q) announced that they had entered into a merger agreement. Under the terms of the agreement, shareholders of IMS Health will receive 0.384 shares of Quintiles common stock for each share of IMS Health they own.

Based in Danbury, Connecticut, and founded in 1954 IMS Health Holdings Inc provides information and technology services to the healthcare industry.

The investigation focuses on whether NYSE: IMS investors received the highest price and whether the directors of IMS Health Holdings Inc acted in the best interest of IMS Health Holdings Inc company and its shareholders.   

If you purchased IMS Health Holdings Inc (NYSE: IMS) prior to May 3, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185